LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0001104659-26-075456 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 18, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
6,435
Total Value
$686,678.85
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 16, 2026 | Exercise/Conversion | 2,145 | $66.13 | $141,848.85 | 35,774 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 16, 2026 | Sale | 2,145 | $254.00 | $544,830.00 | 33,629 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Jun 16, 2026 | Exercise/Conversion | 2,145 | $0.00 | $0.00 | 0 | Direct | โ | View Details |